FDA Grants Priority Review to Eylea HD for Macular Edema Following RVO
QUASAR Phase III study data show higher-dose aflibercept could reduce injection frequency for retinal vein occlusion patients. Bayer (Leverkusen, Germany)…
NexThera, Oculis and Bayer Report Advances in Retinal Disease Therapies
Eye drops and fewer shots: NexThera, Oculis and Bayer move the needle in retinal disease care. NexThera, Bayer and Oculis…
popular posts
latest posts